Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on January 24, 2017, reporting events occurring on January 18, 2017. The filing concerns a leadership transition at Lifecore Biomedical, Inc., a subsidiary of Landec Corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and contains no financial performance data.
Material Changes
The primary material change is the announced retirement of Larry D. Hiebert. Mr. Hiebert will step down as President of Lifecore Biomedical, Inc. and Vice President of Landec Corporation effective June 1, 2017. This date coincides with the week following the end of the Company's fiscal year.
Outlook and Management Commentary
James Hall, currently serving as Vice President and General Manager of Lifecore with over 18 years of tenure at the subsidiary, has been appointed to replace Mr. Hiebert as President of Lifecore. The filing does not include specific financial guidance, risk factors, or contingencies beyond the leadership transition.
Investor Verification Checklist
- Confirm the effective date of the leadership transition (June 1, 2017).
- Verify the new reporting structure for Lifecore Biomedical, Inc. under President James Hall.
- Review the upcoming fiscal year-end report for Landec Corporation to assess any operational impact from this transition.